SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D.Right who wrote (1000)12/9/1997 7:28:00 PM
From: Andrew H  Read Replies (2) of 2173
 
>> One good sign is the price is so pathetic now that even Henry stops coming by and trashing it from time to time. <<

I think even Henry has pity on shareholders at these prices. (:>) I would think the shorts would have better targets than AMLN at these prices, but who knows. I think a lot of people just see dead money for a while and want to put their money to work elsewhere.

However. AMLN in the 5s is awfully cheap. They will most likely get approval for Type1 at least, which will certainly bring the stock to a multiple of its current price. If they were to get approval for type 2 as well, especially given the current trouble with Rezulin, this puppy could really fly.

But it will take time and patience. Good luck to you as well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News